BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36271813)

  • 1. The pre-surgical factors that determine the decision to proceed to resection in children diagnosed with high-risk neuroblastoma in a resource limited setting.
    van Heerden J; Kruger M; Esterhuizen TM; van Zyl A; Hendricks M; Cox S; Mangray H; Poole J; Naidu G; Büchner A; de Villiers M; du Plessis J; van Emmenes B; Matthews E; Manickchund Y; Harrison DS
    Pediatr Hematol Oncol; 2023 Apr; 40(3):242-257. PubMed ID: 36271813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of induction chemotherapy regimens for high-risk neuroblastoma in South African children
    Van Heerden J; Geel J; Hendricks M; Wouters K; Büchner A; Naidu G; Hadley GP; Du Plessis J; Van Emmenes B; Van Zyl A; Vermeulen J; Kruger M
    Pediatr Hematol Oncol; 2020 May; 37(4):300-313. PubMed ID: 32075464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association between Tumour Markers and Meta-iodobenzylguanidine Scans in South African Children with High-risk Neuroblastoma.
    Van Heerden J; Kruger M; Esterhuizen TM; Hendricks M; Du Plessis J; Engelbrecht G; Janse van Vuuren M; van Emmenes B; Uys R; Burger C; Nyakale N; More S; Brink A
    Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):517-526. PubMed ID: 33781675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
    Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of surgical radicality on outcome in childhood neuroblastoma.
    von Schweinitz D; Hero B; Berthold F
    Eur J Pediatr Surg; 2002 Dec; 12(6):402-9. PubMed ID: 12548494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective evaluation of the presentation, prognostic factors and outcomes of neuroblastoma in Ugandan children.
    Nanyanga I; Kwikiriza GK; Atwiine B; Namazzi R; Musiime V; Kambugu JB; van Heerden J
    Pediatr Hematol Oncol; 2023 Apr; 40(3):281-299. PubMed ID: 36562399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.
    Alvarado CS; London WB; Look AT; Brodeur GM; Altmiller DH; Thorner PS; Joshi VV; Rowe ST; Nash MB; Smith EI; Castleberry RP; Cohn SL
    J Pediatr Hematol Oncol; 2000; 22(3):197-205. PubMed ID: 10864050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months.
    Fischer J; Pohl A; Volland R; Hero B; Dübbers M; Cernaianu G; Berthold F; von Schweinitz D; Simon T
    BMC Cancer; 2017 Aug; 17(1):520. PubMed ID: 28778185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of local control management in high-risk neuroblastoma in South Africa.
    van Heerden J; Kruger M; Esterhuizen T; Hendricks M; Geel J; Büchner A; Naidu G; du Plessis J; Vanemmenes B; Uys R; Hadley GP;
    Pediatr Surg Int; 2020 Apr; 36(4):457-469. PubMed ID: 32112128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy.
    Du L; Liu L; Zhang C; Cai W; Wu Y; Wang J; Lv F
    J Pediatr Surg; 2014 Apr; 49(4):528-33. PubMed ID: 24726106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children].
    Fan HJ; Huang C; Su Y; Wang XD; Zhou YC; Duan C; Zhao W; Zhao Q; Jin M; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):863-869. PubMed ID: 31665841
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate analysis of risk factors for patients with stage 4 neuroblastoma who were older than 18 months at diagnosis: a report from a single institute in Shanghai, China.
    Cai J; Pan C; Tang Y; Chen J; Zhou M; Li B; Xue H; Shen S; Gao Y; Zhang A; Tang J
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1327-1335. PubMed ID: 28283783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification.
    Kaneko M; Tsuchida Y; Mugishima H; Ohnuma N; Yamamoto K; Kawa K; Iwafuchi M; Sawada T; Suita S
    J Pediatr Hematol Oncol; 2002 Nov; 24(8):613-21. PubMed ID: 12439032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nomogram for predicting recurrence-free survival of intermediate and high-risk neuroblastoma.
    Sun Q; Chen Y; Jin Q; Yuan X
    Eur J Pediatr; 2022 Dec; 181(12):4135-4147. PubMed ID: 36149505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis.
    Simon T; Häberle B; Hero B; von Schweinitz D; Berthold F
    J Clin Oncol; 2013 Feb; 31(6):752-8. PubMed ID: 23284039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and outcome of stage 3 neuroblastoma.
    Modak S; Kushner BH; LaQuaglia MP; Kramer K; Cheung NK
    Eur J Cancer; 2009 Jan; 45(1):90-8. PubMed ID: 18996003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term follow-ups of comprehensive therapies for stage 4 neuroblastoma].
    Zhang A; Pan C; Ye Q; Zhou M; Chen J; Luo C; Wang J; Tang Y; Xue H; Shen S; Tang J
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1547-52. PubMed ID: 25146742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study.
    Adkins ES; Sawin R; Gerbing RB; London WB; Matthay KK; Haase GM
    J Pediatr Surg; 2004 Jun; 39(6):931-6. PubMed ID: 15185228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.